NCT06385184 Social & QoL Behaviors in Parkinson's Disease
| NCT ID | NCT06385184 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gregory Wallace |
| Condition | Parkinson Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-03-08 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-03-08 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Adults with Parkinson's Disease experience an array of challenges and changes in daily living, behaviors, and functioning throughout the progression of their condition. The investigators want to learn more about the effects of Parkinson's Disease on individuals' social behavior and quality of life (QoL) compared to people of the same age without Parkinson's Disease.
Eligibility Criteria
Parkinson's disease group Inclusion Criteria: * Have been diagnosed with Parkinsons Disease by a healthcare professional * Are at least 40 years old Exclusion Criteria: * Possess a diagnosis of autism or any other developmental disability (e.g., Down syndrome) Neurotypical group Inclusion Criteria: * Are at least 40 years old Exclusion Criteria: * Have been diagnosed with Parkinson's disease by a healthcare professional * Possess a diagnosis of autism or any other developmental disability (e.g., Down syndrome)
Contact & Investigator
Gregory Wallace, PhD
PRINCIPAL INVESTIGATOR
George Washington University
Frequently Asked Questions
Who can join the NCT06385184 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06385184 currently recruiting?
Yes, NCT06385184 is actively recruiting participants. Contact the research team at ladn@gwu.edu for enrollment information.
Where is the NCT06385184 trial being conducted?
This trial is being conducted at Washington D.C., United States.
Who is sponsoring the NCT06385184 clinical trial?
NCT06385184 is sponsored by Gregory Wallace. The principal investigator is Gregory Wallace, PhD at George Washington University. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.